Trials / Completed
CompletedNCT05874622
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
A Randomized, Double-blind, Dose-escalating, Placebo-controlled Phase Ib Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, dose-escalating, placebo-controlled phase Ib clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VC005 tablets | VC005 groups repeat administration for 4 weeks |
| DRUG | VC005 Tablets Placebo | VC005 placebo groups repeat administration for 4 weeks |
Timeline
- Start date
- 2023-06-12
- Primary completion
- 2023-10-18
- Completion
- 2023-10-25
- First posted
- 2023-05-25
- Last updated
- 2023-11-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05874622. Inclusion in this directory is not an endorsement.